An ideal combination: The vaccine A is obtained by conjugation of the synthetic tumor-associated sialyl-TN-MUC1 glycopeptide antigen to tetanus toxoid (molecular weight >150 000). Vaccine A induces a very strong and selective immune response against the glycopeptide structure in wild-type mice (Balb/c).
No takes yet. Share an insight, caveat, or question.
Kaiser et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: